March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
Excerpts from recent editorials in the United States and abroad: ___ Nov. 9 The Washington Post says TrumpRx isn't the best way to lower prices In a landmark deal announced Thursday, President Donald ...
Is Religion Still Relevant? Leaders from four major religions gathered for interfaith dialogue at one of Britain’s most ...
Stifel 2025 Healthcare Conference November 11, 2025 9:20 AM ESTCompany ParticipantsKim Kelderman - CEO, President ...
Capricor Therapeutics, Inc. ( CAPR) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Third Quarter 2025 Conference ...
Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...
Interesting Engineering on MSN
Scientists achieve targeted seizure control using sound waves and gene therapy
Bioengineers at Rice University have developed a nonsurgical method to control seizure-related brain activity using sound ...
Type 1 diabetes is an autoimmune disease in which the insulin-producing β cells in the pancreatic islets of Langerhans are ...
The obligations and responsibilities of governments and drug companies to increase access to costly new drugs should be grounded in international human rights, write Trudo Lemmens and colleagues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback